Inmune Bio INMB
NASDAQ INMB
$1.10 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Inmune Bio (INMB) Depreciation & Amortization (CF) (2025 - 2026)

Updated

Inmune Bio (INMB) recorded Depreciation & Amortization (CF) of $100,000 in Q2 2026, up 92.3% from the prior quarter.

Analysis

Inmune Bio (INMB) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends

For FY2025, Inmune Bio reported Depreciation & Amortization (CF) of $84,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Inmune Bio 30.71 Mn -50.14 Mn - 100,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 100,000.00
Jun 30, 2026 100,000.00
Mar 31, 2026 52,000.00
Dec 31, 2025 56,000.00
API Access

Inmune Bio Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=INMB&period=max&api_key=YOUR_API_KEY